Navigation Links
The American Parkinson Disease Association Awards $1.5 Million in Research Grants

With a new PD diagnosis every nine minutes, research is critical as we push for better treatments and ultimately, a cure.

The grants are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board (SAB) which is comprised of scientists with a wide array of backgrounds and expertise in all areas relevant to PD research. The SAB meets annually to review all grant proposals and set the scientific direction of APDA’s annual research investment. Their focus is to identify researchers early in their careers and attract them to the PD field, as well as to help established investigators pursue new and novel ideas. In many cases these projects produce significant pilot data, which has enabled researchers to apply for and receive multimillion dollar research grants from the National Institutes of Health and other funding institutions.

“There is an urgent need to accelerate research and support translational ideas that have the potential to truly improve the quality of life for people living with PD,” commented David G. Standaert, MD, PhD, John N. Whitaker Professor, Chair of Neurology at the University of Alabama at Birmingham, School of Medicine and Chairman of the SAB. “Now is a time of tremendous excitement in Parkinson’s research. The objective of the SAB is to invest in the best science that will move the field forward, to slow or cure the disease.”

APDA has been a funding partner in many of the significant Parkinson’s scientific discoveries in the last 50 years including the work of Dr. George C. Cotzias, which led to establishing the effectiveness of levodopa in treating PD; this treatment remains the gold standard in PD treatment today.

“The work being done as a result of the grants in this new funding cycle will have an incredible impact on the world of PD,” stated Leslie A. Chambers, President & CEO of APDA. “We are truly excited about the range of projects we are able to support - from neuroprotection that can slow the progress of the disease, to biomarkers which can help measure the activity of the disease, to novel ideas such as wearables and evidence-based non-medical therapies that can help improve quality of life. The questions posed by our researchers span a broad and exciting range of areas. This work is only possible because of the steadfast support of our generous APDA donors.”

Post-Doctoral Fellowships were awarded to support post-doctoral scientists whose research holds promise to provide new insights into pathophysiology, etiology and treatment of PD:

  • Xu Hou, PhD, Mayo Clinic, Jacksonville, FL
  • Md Shariful Islam, PhD, Van Andel Institute, Grand Rapids, MI
  • Isabel Lam, PhD, The Brigham and Women’s Hospital, Boston, MA
  • An Phu Tran Nguyen, PhD, Van Andel Institute, Grand Rapids, MI

Research Grants were awarded to investigators affiliated with and performing PD research at major academic institutions across the United States.

  • Joseph DeGutis, PhD, and Alice Cronin-Golomb, PhD, Boston University School of Medicine, Boston, MA
  • Xianjun Dong, PhD, The Brigham and Women’s Hospital, Boston, MA
  • Michael L. Gross, PhD, Washington University School of Medicine, St. Louis, MO
  • Andreas H. Kottmann, PhD, City College of New York, New York City, NY
  • Beom-Chan Lee, PhD, University of Houston, Houston, TX
  • Xiaobo Mao, PhD, Johns Hopkins University School of Medicine, Baltimore, MD
  • Ignacio F. Mata, PhD, Seattle Institute for Biomedical and Clinical Research, Seattle, WA
  • Rahul Srinivasan, PhD, Texas A&M Health Science Center, Bryan, TX
  • Yulan Xiong, PhD, Kansas State University, Manhattan, KS
  • Talene Yacoubian, MD, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL
  • Tonya Zeczycki, PhD, East Carolina University, Greenville, NC

APDA Centers for Advanced Research support large research programs which include research trainees, fellowship programs, early stage discovery programs and later stage clinical translation. These Centers facilitate research which is at the forefront of investigation into the cause, treatment and ultimately cure for PD.

  • Boston University School of Medicine, Boston, MA
  • David Geffen School of Medicine at UCLA Medicine, Los Angeles, CA
  • Emory University School of Medicine, Atlanta, GA
  • Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
  • University of Alabama at Birmingham, School of Medicine, Birmingham, AL
  • University of Pittsburgh Medical Center, PA
  • University of Virginia Health System, Charlottesville, VA
  • Washington University School of Medicine, St. Louis, MO

Learn more about these grantees and the exciting work they are doing and browse all APDA funded research.

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related medicine news :

1. Florida Hospital and the American Heart Association Inspire Women to Share Their Stories on Heart Disease and Stroke
2. American Psychiatric Nurses Association Welcomes Members to Board of Directors and 2018 Nominating Committee
3. CareDx Describes Extensive Analytical Validation Data on AlloSure Robustness at American Association of Clinical Chemistry Annual Meeting
4. As Lifestyle Medicine Continues to Emerge As Medicine’s Fastest Growing Field, Hundreds Register For First-Ever American Board Of Lifestyle Medicine Certification Exam
5. Author David Johnson’s Newly Released “Jim Kersting: An American Dream” Is the Story of Achieving the American Dream from the Humble Beginnings of a Midwestern Farm Boy
6. Distinguished Dentist in Denville, NJ, Dr. Adam Kimowitz, Becomes Diplomate of the American Board of Oral Implantology/Implant Dentistry
7. American Farmer Proudly Announces Syngenta Participation in Upcoming Episode
8. North American Veterinary Heart Center Sets the Global Standard for Dog and Cat Cardiac Surgery
9. Therachat to Exhibit at the 125th American Psychological Association Annual Convention
10. Discovering Advances in Animal Health Technology on American Farmer
11. Lifestyle Medicine Institute Takes Seat as Newest Founding Member of the American College of Lifestyle Medicine Corporate Roundtable
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
(Date:10/4/2017)... 2017  According to the Centers for Disease Control and Prevention (CDC), ... PhysicianOne Urgent Care is helping communities across Massachusetts , ... by offering no-cost* flu shots through the end of the month. ... insurance regulations. ... get a flu shot is by the end of October, according to ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, the ... by Walgreens and pharmacy benefit manager Prime Therapeutics LLC ... brand, which included the unveiling of new signage at ... as well as at a few other company-owned facilities ... brand to patients, some of whom will begin to ...
Breaking Medicine Technology: